Alnylam Pharmaceuticals Inc (ALNY)
144.39
-0.62
(-0.43%)
USD |
NASDAQ |
Apr 19, 16:00
144.39
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Return Level: 145.01 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 145.01 |
April 17, 2024 | 145.32 |
April 16, 2024 | 146.72 |
April 15, 2024 | 147.70 |
April 12, 2024 | 148.50 |
April 11, 2024 | 152.09 |
April 10, 2024 | 152.41 |
April 09, 2024 | 155.90 |
April 08, 2024 | 156.04 |
April 05, 2024 | 153.56 |
April 04, 2024 | 151.48 |
April 03, 2024 | 150.83 |
April 02, 2024 | 151.04 |
April 01, 2024 | 153.33 |
March 28, 2024 | 149.45 |
March 27, 2024 | 154.39 |
March 26, 2024 | 151.97 |
March 25, 2024 | 152.07 |
March 22, 2024 | 146.51 |
March 21, 2024 | 146.62 |
March 20, 2024 | 147.99 |
March 19, 2024 | 148.17 |
March 18, 2024 | 147.41 |
March 15, 2024 | 149.27 |
March 14, 2024 | 148.53 |
Date | Value |
---|---|
March 13, 2024 | 148.42 |
March 12, 2024 | 146.65 |
March 11, 2024 | 149.10 |
March 08, 2024 | 149.82 |
March 07, 2024 | 149.86 |
March 06, 2024 | 149.66 |
March 05, 2024 | 149.68 |
March 04, 2024 | 150.04 |
March 01, 2024 | 152.61 |
February 29, 2024 | 151.09 |
February 28, 2024 | 155.23 |
February 27, 2024 | 159.00 |
February 26, 2024 | 158.66 |
February 23, 2024 | 157.65 |
February 22, 2024 | 162.81 |
February 21, 2024 | 154.74 |
February 20, 2024 | 149.69 |
February 16, 2024 | 147.00 |
February 15, 2024 | 147.43 |
February 14, 2024 | 164.15 |
February 13, 2024 | 162.00 |
February 12, 2024 | 169.34 |
February 09, 2024 | 170.03 |
February 08, 2024 | 169.50 |
February 07, 2024 | 168.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
65.86
Minimum
May 20 2019
241.31
Maximum
Dec 21 2022
154.92
Average
152.82
Median
Total Return Level Benchmarks
Ionis Pharmaceuticals Inc | 40.81 |
Pfizer Inc | 86.78 |
Blueprint Medicines Corp | 88.89 |
Madrigal Pharmaceuticals Inc | 222.59 |
Sarepta Therapeutics Inc | 116.51 |